Amagasaki, Japan

Yoko Nanjo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Oji Paper Co., Ltd., Oji Scientific Instruments Co., Ltd. Active years: 2012.



Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoko Nanjo: Innovator in Glycosylated Hemoglobin Analysis

Introduction

Yoko Nanjo is a prominent inventor based in Amagasaki, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the analysis of glycosylated hemoglobin. Her innovative work has led to the development of advanced methods and apparatuses that enhance the accuracy of medical testing.

Latest Patents

Yoko Nanjo holds a patent for an "Analysis apparatus and analysis method for glycosylated hemoglobin." This invention discloses a method for calculating the ratio of glycosylated hemoglobin with high accuracy by electrochemically detecting the concentration of fructosyl valine or fructosyl valyl-histidine in a sample. Additionally, the patent describes an apparatus for assaying glucose and glycosylated hemoglobin simultaneously, as well as methods for removing hydrogen peroxide from samples.

Career Highlights

Throughout her career, Yoko has worked with notable companies such as Oji Scientific Instruments Co., Ltd and Oji Paper Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in medical technology.

Collaborations

Yoko has collaborated with various professionals in her field, including Ryuzo Hayashi. These partnerships have fostered innovation and have been instrumental in the development of her patented technologies.

Conclusion

Yoko Nanjo's contributions to the analysis of glycosylated hemoglobin demonstrate her commitment to improving medical diagnostics. Her innovative methods and apparatuses continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…